Key result
PD-1-deficient mice exhibited a more mature NK cell phenotype with decreased tumor infiltration and faster PD-L1 membrane migration compared to wildtype mice.
PD-1 deficiency alters the phenotype of tumor-infiltrating NK cells, suggesting PD-1 and PD-L1 form cis interactions on NK cells.
Should not yet alter PD-1 inhibitor use; leaves open NK cell roles in human tumors.
ABSTRACT Although PD-1 was shown to be a hallmark of T cells exhaustion, controversial studies have been reported on the role of PD-1 on NK cells. Here, we found by flow cytometry and single cell RNA sequencing analysis that PD-1 can be expressed on MHC class I-deficient tumor-infiltrating NK cells in vivo. We also demonstrate distinct alterations in the phenotype of PD-1-deficient NK cells which in part could be attributed to a decrease in tumor-infiltrating NK cells in PD-1-deficient mice. NK cells from PD-1-deficient mice exhibited a more mature phenotype which might reduce their capacity to migrate and kill in vivo. Finally, our results demonstrate that PD-L1 molecules in membranes of PD-1-deficient NK cells migrate faster than in NK cells from wildtype mice, suggesting that PD-1 and PD-L1 form cis interactions with each other on NK cells.
No takes yet. Share an insight, caveat, or question.
Werf et al. (2013) studied this question. PD-1 deficiency vs. Wildtype mice was evaluated on NK cell phenotype and migration. PD-1-deficient mice exhibited a more mature NK cell phenotype with decreased tumor infiltration and faster PD-L1 membrane migration compared to wildtype mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: